2026-10-08 · 2026-10 / week-2
LEVI’s Tariff-Aided Q3 Beat Does Not Bound a Short
LEVI’s Tariff-Aided Q3 Beat Does Not Bound a Short
Summary: Levi Strauss beat adjusted-EPS expectations, missed revenue consensus slightly, and raised its full-year profit outlook after a quarter whose reported margin expansion was heavily helped by tariff refunds. The $19.15 after-hours mark sits near the bottom of a wide historical range, while management said U.S. DTC trends had turned positive heading into Q4 and announced a planned $100 million ASR. The first-session map offers less than 10% downside in its top historical case and more than 5% upside in its adverse case. Reject; no trade.
Scope: U.S.-listed common stocks, short opportunities only.
Publication time: 2026-10-08 12:43 Asia/Singapore.
Market observation: LEVI closed at $19.51 on Oct. 7, down 4.97%, on 18.03 million shares. The earnings call began after the close. ChartMill showed $19.1497 at 8:04 p.m. EDT, down 1.85% from the close; StockScan separately displayed $19.15 after hours. This is the latest timestamped extended-hours reference found in this run, not a current pre-market NBBO or executable entry.
Status: Reject / no-trade screen. The new filing materially changes the earlier July long thesis: DTC growth and margin quality were weaker than that thesis expected, but Q3 organic revenue still grew 5%, the company raised full-year margin/EPS guidance, and the call described better early-Q4 DTC trends. A reference-only map has a flat base, a 7.5% historical downside stress and a 6.5% adverse rebound stress. The short fails 10/5 before costs.
Opportunity Ranking
| Rank | Candidate | Direction | Mispricing | Evidence Freshness | Catalyst Window | Positioning | 10/5 Status | Tradeability | Main Rejection Risk |
|---|---|---|---|---|---|---|---|---|---|
| 1 | LEVI | Short screen | Q3 adjusted EPS beat, but revenue missed slightly and much of reported margin expansion came from tariff refunds; DTC comparable sales were flat. | Oct. 7 issuer Q3 results and call; Oct. 7 close and 8:04 p.m. EDT after-hours quote | First post-result regular session Oct. 8; FY26 year ends Nov. 29 | Latest located settlement Sep. 15: 8.046M shares short; providers disagree on float percentage; borrow and locate unknown | Reject: top historical downside 7.5%, base flat, adverse near-session-high rebound +6.5%; 0:1 | NYSE large-cap; current spread, depth, borrow/recall, venue quality and exit capacity unverified | The full-year guide was raised and management reported early-Q4 DTC improvement; planned ASR may support demand |
| 2 | APLD | Short screen | Q1 GAAP loss widened sharply while adjusted EBITDA and lease metrics improved; fit-out revenue is large and highly project-timed. | Oct. 7 issuer Q1 release; Oct. 7 close and 7:59 p.m. EDT after-hours mark | First post-result regular session Oct. 8; new campus delivery and project-financing milestones | Sep. 15 settlement short interest was 57.86M shares (21.88% reported float; 3.36 days to cover); stale, current borrow unknown | Reject: financing and construction gaps make the upside tail unbounded; no defensible 10/5 valuation map | Nasdaq; 48.76M shares traded Oct. 7, but locate, borrow, spread, depth and intended-size exit remain unchecked | 1.41 GW of executed leases, $3.7B cash including restricted cash, and a 4.75% after-hours rebound can fuel a squeeze |
| 3 | PEP | Short screen | Q3 results are due before the open, but the Q2 weakness cited by previews is not yet updated by the scheduled release. | Latest issuer results July 9; Oct. 8 release schedule confirmed Aug. 25 | Q3 materials scheduled for about 6:00 a.m. EDT; analyst Q&A at 8:15 a.m. EDT | Current positioning not reviewed | Reject for this run: no new result or post-release price acceptance | Nasdaq mega-cap; execution conditions not audited | International growth, product actions or a North America improvement could counter the bearish preview |
| 4 | SPY | Broad-market control | No index-specific short catalyst; the S&P 500 fell 0.2% on Oct. 7. | Oct. 7 completed market close | None selected | Index positioning not underwritten | No setup | Highly liquid, but liquidity is not a thesis | Rates and the market’s earnings outlook may dominate the single-name reaction |
Selected opportunity: LEVI for information value, not because it is the best executable short. Its Q3 release and call directly test the July LEVI long thesis’s two main claims: that post-Dockers growth was broad and that margin expansion could persist despite tariffs.
Why this one now: The earlier long article was based on Q2 results, the pending $200 million ASR settlement, and management’s $1.46–$1.52 adjusted-EPS guide. The new boundary is Q3 actuals: the ASR settled, the company took delivery of and retired 1.6 million shares during Q3, DTC comparable sales were flat and management disclosed an $84 million gross tariff-refund benefit, partly redeployed. The thesis has changed because primary evidence arrived, not because the quote moved or the direction is being flipped.
RELL was screened but not ranked again: its Oct. 7 results already have a same-day Desk screen, and its scheduled Q1 call has not yet occurred. Reusing that setup without new issuer evidence would repeat yesterday’s thesis boundary.
What should surprise the reader: The adjusted-EPS beat looks much smaller after the issuer’s own tariff bridge. Adjusted EPS was $0.48 against a secondary consensus of $0.36, but Levi reported $0.16 per share of tariff-refund benefit and about $0.05 redeployed, leaving an issuer-described net benefit of $0.11. A simple subtraction gives $0.37, only one cent above that consensus estimate. This is a sensitivity, not a replacement GAAP or company-adjusted figure. Yet revenue grew organically 5%, the full-year profit guide rose, and call commentary said U.S. DTC had returned to positive territory in early Q4. Neither side of that evidence supports a bounded short.
Why This Is the Best Opportunity Right Now
LEVI has the freshest complete issuer result in the screen. Q3 continuing-operations revenue was $1.610 billion, up 4.3% reported and 4.5% organically. Organic Americas revenue rose 2.5%, Europe 4.7%, and Asia 9.6%. The weaker spots matter: U.S. reported revenue fell 1%; DTC comparable sales were flat; and management said DTC fell short of its internal expectation. Global wholesale organic revenue rose 6.3%, giving the quarter a counterweight to DTC softness.
Reported gross margin expanded to 66.2% from 61.7%, while adjusted EBIT margin rose to 15.5% from 11.8%. The company attributed 490 basis points of margin expansion to tariff refunds, of which about 160 basis points were redeployed in the quarter, leaving a net 330-basis-point benefit. Excluding that disclosed net benefit by simple subtraction leaves a 12.2% margin, versus 11.8% a year earlier. That illustrative comparison suggests only 40 basis points of underlying margin improvement; it is not a management-reported normalized margin and it excludes any interacting mix or cost effects.
Guidance cuts both ways. Full-year organic revenue growth moved to about 6.0% from a 5.5%–6.0% range, adjusted EBIT margin to about 12.1% from 12.0%, and adjusted EPS to $1.54–$1.56 from $1.46–$1.52. But the revised outlook explicitly includes tariff-refund effects and assumes current tariff rates persist. At the $19.15 after-hours reference, the price is about 12.4× the $1.55 midpoint. That ratio is not a complete valuation: it uses management’s adjusted metric, includes refund assumptions, and does not reconcile debt, leases or all share classes.
The strongest bearish interpretation is that a small revenue miss, flat DTC comps and refund-affected margins make the Q3 EPS beat less durable than its headline implies. The strongest counterargument is equally concrete: the quarterly cash and earnings data are real, inventory was down 3% year over year, guidance rose, and management told analysts that U.S. DTC trends had turned positive and quarter-to-date global DTC was tracking at mid-single digits. That last statement is management commentary, not a completed-quarter result.
Why This Can Move More Than 5% Soon
The release is post-close, so the next regular session is the cleanest observable test. The Oct. 7 regular high of $20.39 is 6.5% above the $19.15 after-hours reference; the $17.72 52-week low is 7.5% below it. These are historical price stresses, not valuation targets or bounds. The brief shows that moves beyond 5% are plausible, but the observed downside reference still falls short of the required 10% favorable base and the upside reference already breaches the 5% adverse limit.
The cheapest falsification is the Oct. 8 regular-session close and volume alongside the actual NBBO/depth for a specified short size. A close recovering the $20.39 Oct. 7 high would weaken the fade case; another decline alone would not establish a fundamental valuation gap. The next operating test is Q4 and full-year results for the period ending Nov. 29, including DTC comparable sales, gross and adjusted EBIT margins, tariff-refund amounts and reinvestment, inventory, cash conversion and the planned $100 million ASR’s actual execution.
10/5 Asymmetry Gate
The measurement basis is $19.15, ChartMill’s timestamped Oct. 7 8:04 p.m. EDT after-hours print (corroborated to the cent by StockScan). It is a reference, not an executable entry. The stated holding window is through the Oct. 8 post-result regular close. The $17.72 52-week low and $20.39 Oct. 7 high are observed historical levels; neither is fair value or a loss cap.
- Reference-only top case for a short: $17.72, the 52-week low recorded March 20, 2026, or 7.5% underlying downside. It does not reach the required 10%, and it is not an earnings-derived valuation.
- Highest-probability base case: $19.15, or 0% underlying return. The late after-hours quote sits below the regular close but the evidence does not establish a sustained regular-session trend after the release.
- Reference-only bottom case for a short: $20.39, the Oct. 7 regular-session high, or a 6.5% adverse rise. It was reached before the release and does not cap future short losses.
- Subjective weights: 15% / 60% / 25%. The largest weight is near the latest after-hours mark because Q3 was mixed rather than a clear operating break. The lower historical-low case receives 15% because the issuer still grew organic sales and raised profit guidance; a rebound to the Oct. 7 high receives 25% given those countervailing results and management’s Q4 DTC commentary. This is a low-confidence scenario judgment, not a calibrated frequency.
- Probability-weighted price: 0.15 × $17.72 + 0.60 × $19.15 + 0.25 × $20.39 = $19.2455.
- Gross price-only expected short return: approximately -0.5% before borrow, recall, the $0.16 dividend payable Nov. 4 if held through the relevant ex-date, spread, slippage, fees and path effects.
- Sensitivity: A more bearish 30% / 60% / 10% mix gives a weighted price of $18.845, or +1.6% gross price-only short value. The base remains flat and the adverse case remains +6.5%.
- Gross base reward / adverse risk: 0% / 6.5% = 0:1.
10/5 status: Reject. The highest-probability case is flat, the strongest historical downside reference is only 7.5%, the adverse rebound stress exceeds 5%, the base/adverse ratio is 0:1, and the expected price-only short return is negative before costs.
The Setup
Levi Strauss sells Levi’s and related apparel through wholesale and direct-to-consumer channels. Its Q3 FY2026 release reports on continuing operations after Dockers was classified as discontinued. Net revenue was $1.610 billion versus $1.543 billion a year earlier. U.S. reported revenue declined 1%; Asia organic revenue rose 9.6%, Europe 4.7%, and global organic revenue 4.5%. DTC was 45% of revenue; global DTC grew 2% reported, while comparable sales were flat. Wholesale grew 6.3% organically.
Reported Q3 continuing-operations diluted EPS was $0.43 and adjusted diluted EPS was $0.48, versus $0.31 and $0.34 respectively. The issuer’s notes say the $84 million tariff refund comprised $79 million in cost of goods sold and $5 million of interest income; $25 million of refund was redeployed into business expenses, including $19 million through gross margin and $6 million through SG&A. The company describes the net adjusted-EPS benefit as $0.11. The market can reasonably value the remaining $0.37 sensitivity differently from $0.48, but it should not be confused with the issuer’s actual adjusted result.
The Q3 balance sheet had $641 million cash and about $1.5 billion of total liquidity. August 30 shares outstanding were 99.255 million Class A and 284.215 million Class B, so a roughly 383.470 million total-share denominator is relevant to a cross-class market-cap proxy. Long-term debt was $1.044 billion. This capitalization and debt snapshot is dated; it is not a live enterprise-value reconciliation.
The Q3 $200 million ASR, launched in Q1, settled during the quarter. The company took delivery and retired 1.6 million shares in Q3; 9.4 million had been retired across the full program. Separately, Levi stated an intention to initiate another $100 million ASR and had $240 million under its unexpired authorization. The new $100 million plan is intention, not completed repurchase. The $0.16 dividend was payable Nov. 4 to record holders on Oct. 21; a future short may incur the corresponding payment in lieu, subject to actual stock-loan terms.
The Market Price
StockAnalysis records the Oct. 7 regular session at $19.51, down 4.97% from $20.53, on 18,029,690 shares, with a $19.35–$20.39 range. The day was a regular-session move before the scheduled 5:00 p.m. EDT call and after-close earnings discussion; do not label it a verified post-results regular-session return. The latest after-hours observations found were $19.1497 at 8:04 p.m. EDT from ChartMill and $19.15 after hours from StockScan. MarketBeat showed $19.17 at 7:59 p.m. EDT. The 2-cent provider/time difference is small but unresolved; the scenario map uses ChartMill’s timestamped print without averaging.
On the same date, the S&P 500 fell 0.2%. The Nasdaq Composite also fell 0.2%, while the Russell 2000 fell 1.3%. LEVI’s 4.97% regular-session decline underperformed the broad indices, but the earnings release and call were after the session. Attribution to the report is therefore not established. The late after-hours weakness is an observed reaction, not a completed regular-session acceptance.
The Mispricing
The possible short-side disagreement is that the market may be giving too much credit to the Q3 adjusted-EPS beat when a one-time tariff refund accounted for $0.11 of adjusted EPS and 330 basis points of adjusted EBIT-margin expansion after redeployment. DTC comps were flat, U.S. revenue was down 1%, and the first regular session sold off sharply.
The issue is what remains after removing that benefit. A simple margin subtraction leaves 12.2% adjusted EBIT margin versus 11.8% in Q3 2025. Organic revenue grew 5%; wholesale grew 6%; Asia grew 10%. The adjusted EPS subtraction of $0.11 leaves $0.37, only one cent above the pre-release $0.36 consensus estimate, but Q3 continuing earnings still rose and the full-year adjusted-EPS guide rose to $1.54–$1.56. The market’s late after-hours decline could reflect a miss against higher expectations or concern about DTC; public evidence does not establish that a durable profit break has begun.
This is a materially changed evidence boundary from the July long article, not a reissued version of that thesis. The prior piece argued Q2 growth and the pending $200 million ASR settlement were being underpriced. The new Q3 result confirms one real operating improvement (EPS and margin after refund adjustment) while introducing two risks that were not adjudicated then: flat DTC comps and a large tariff-refund component. The new report does not resolve valuation, and the short still fails the payoff rule.
The Positioning
The latest located FINRA settlement report is dated Sep. 15 and records 8,045,787 LEVI shares short, up 13.7% from Aug. 31. Positioning vendors disagree materially on the float denominator: ChartMill reports 8.18% of float and 3.65 days to cover, while MarketBeat reports 2.11% of public float and 3.8 days using a 2.72-million average-volume figure. The absolute share count matches; the percentage discrepancy is unresolved and not evidence of a live squeeze or borrow condition. At 18.03 million regular-session shares on Oct. 7, trading volume was unusually high, but buyer identities and post-result stock loans remain unknown. Positioning score: 3/5.
The Catalyst
| Step | State at publication | Cheapest test | Consequence for the short thesis |
|---|---|---|---|
| Q3 FY2026 results | Issuer release posted Oct. 7; Q&A held at 5:00 p.m. EDT | Reconcile Q3 organic revenue, tariff refunds, redeployment, DTC comps and segment margins against the release and call transcript | Actuals weaken a pure growth story but do not show an earnings collapse |
| First post-result regular session | Oct. 8 U.S. session is ahead; the $19.15 mark is after-hours only | Record regular close, volume, spread and depth after the overnight reaction | A reclaim above $20.39 challenges a fade; weakness alone is not a valuation bridge |
| Q4 / FY2026 | Fiscal year ends Nov. 29, 2026 | Reconcile DTC recovery, full-year realized tariff refunds/reinvestment, organic growth, margin, EPS and cash conversion | Confirms or rejects management’s stated mid-single-digit Q4 DTC recovery |
| Planned $100M ASR | Announced intention; not yet evidenced as commenced or settled | Check a later filing for authorization, execution, delivered shares and denominator effect | Actual retirement may support per-share value; authorization alone is not demand |
The cheapest falsifier of the short case is the Oct. 8 regular-session close and volume alongside the actual NBBO/depth for a specified short size. A close recovering the $20.39 Oct. 7 high would weaken the fade case; another decline alone would not establish a fundamental valuation gap. The next operating test is Q4 and full-year results for the period ending Nov. 29, including DTC comparable sales, gross and adjusted EBIT margins, tariff-refund amounts and reinvestment, inventory, cash conversion and the planned $100 million ASR’s actual execution.
The Payoff
The one-session reference map through the Oct. 8 regular close uses the latest timestamped after-hours mark and nearby observed prices. The $17.72 52-week low and $20.39 Oct. 7 high are historical stress markers only. The short’s favorable reference case is less than 10%, the base is unchanged, and the adverse rebound exceeds 5%. The limited horizon is appropriate for first-session acceptance; it does not price the longer Q4 operating thesis.
Price Target and Probability Map
| Scenario | Probability | Target / Level | Return / Payoff | Horizon | Conditions | Evidence Quality |
|---|---|---|---|---|---|---|
| Top case for short | 15% | $17.72 | +7.5% underlying short return | Through Oct. 8, 2026 regular close | Post-release weakness extends toward the 52-week low despite raised guide | Low; historical-price stress, not valuation |
| Base case | 60% | $19.15 | 0% underlying return | Through Oct. 8, 2026 regular close | Mixed results are absorbed near the late after-hours mark pending regular-session acceptance | Low; unchanged-price reference |
| Bottom case for short | 25% | $20.39 | -6.5% underlying short return | Through Oct. 8, 2026 regular close | Raised guidance, Q4 DTC commentary and share repurchase intentions draw price back to the Oct. 7 high | Medium as an observed level; not a cap |
| Invalidation | n/a | Rebuild after regular-session acceptance and Q4/FY26 evidence | n/a | Any time | Current-session recovery plus reported DTC/margin conversion contradicts the post-Q3 fade premise | Medium that these are relevant tests; outcome unknown |
Probability-weighted expected value: weighted price $19.2455, or approximately -0.5% gross price-only short return before carry and execution costs.
Current market level and timestamp: $19.1497 at Oct. 7, 2026 8:04 p.m. EDT (ChartMill after-hours reference); StockScan displayed $19.15 after hours and MarketBeat $19.17 at 7:59 p.m. EDT. These are not blended or treated as executable.
Primary instrument: None. LEVI common shares are the screened underlying only.
10/5 favorable base move: 0% underlying decline.
10/5 credible adverse move: +6.5% to the observed Oct. 7 high; upside beyond it is not capped.
10/5 measurement basis: Reference-only after-hours observation; entry remains null.
10/5 status: Reject.
Confidence: Low. Issuer results, call commentary and after-hours mark are sourced, but valuation of normalized earnings, current borrow and first-session acceptance are unresolved.
The Kill Shot
The strongest counterparty argument is not that tariff refunds recur. It is that the share price already sits near the bottom of its 52-week range while the operating business keeps growing, full-year adjusted EPS guidance rises, and the planned $100 million ASR comes on top of completed Q3 share retirement. Management said its actions to address U.S. DTC traffic were already producing positive trends in early Q4 and that quarter-to-date global DTC was tracking mid-single digits. That is management commentary, but it is a direct challenge to the short’s nearest catalyst.
The load-bearing bearish assumption is that the flat Q3 DTC comp and tariff-normalized margin will outweigh wholesale, Asia and improved Q4 trends. It is fragile: the Q3 margin still improved after a simple tariff-benefit subtraction, and the first-session adverse path is already greater than 5%. The short can lose even if the margin is less repeatable than reported because the share count can fall through a completed ASR, the company can outperform its cautious guide, or price can gap through the historical stress.
What Could Go Wrong
- Q3 revenue exceeded $1.6 billion and organic revenue rose 5%; growth outside U.S. DTC may keep estimates from falling.
- Net tariff-refund benefit was $0.11 per adjusted share, but the company redeployed $25 million in Q3 and expects another $35 million during Q4; headline-to-normalized comparisons must be period-aligned.
- Management’s Q4 DTC recovery is unverified, but it is a credible squeeze catalyst, not something a short can dismiss.
- The company intends a new $100 million ASR; actual execution and delivery remain unknown.
- 8.046 million shares short at Sep. 15 is stale; vendor float percentages conflict and neither borrow cost nor recall terms is known.
- After-hours quotes are thin and can reverse; the $20.39 session high does not bound a gap.
- The $0.16 dividend scheduled for Nov. 4 may create a payment-in-lieu cost if a short remains open past the ex-date.
What Would Prove This Wrong
The post-Q3 short screen is wrong if the Oct. 8 regular session accepts above $20.39 and Q4 reporting later shows mid-single-digit DTC growth with the issuer’s 12.1% adjusted EBIT-margin guide substantially achieved. That would retire the short premise; it would not validate the earlier July long valuation. Conversely, a decline on Oct. 8 is not enough to prove a short without evidence that tariff-normalized margins or full-year guidance are deteriorating.
Risk Audit
The 8:04 p.m. EDT reference is a secondary after-hours print; no consolidated NBBO, current premarket quote, spread, depth, venue mix or realistic exit size was checked. Short interest is stale to Sep. 15 and its float denominator is disputed across data vendors. Borrow availability, fee and recall risk are unknown. A short could lose through an overnight gap, Q4 guidance confirmation, actual share retirement, a dividend payment in lieu, or a rebound greater than the historical high. There is no protective option structure here: no live option chain, spread or maximum-loss analysis was performed.
Best Trade Strategy
No trade. Keep entry.price null and execution blocked. Re-screen after the Oct. 8 regular-session close with verified quote, locate, borrow/recall, spread, depth and intended-size exit capacity, and only if an operating/valuation model supports at least a 10% highest-probability decline, no more than 5% credible adverse rise, 2:1 gross reward/adverse risk and positive expected value after costs. No options, leverage, margin, market orders or price-floor logic.
An unlevered common short would carry open-ended upside and borrow recall risk. A put or put spread could define loss, but no live chain, bid/ask, implied volatility, open interest or max-loss comparison was verified, so no derivative expression is evaluated here.
Sources
| Source | Date / timestamp | Use |
|---|---|---|
| Levi Strauss Q3 FY2026 issuer release | Oct. 7, 2026 | Revenue, segments, DTC, margin, tariff refund, EPS, balance sheet, ASR, dividend and raised FY guidance |
| Levi Strauss Q3 call transcript | Call held Oct. 7, 2026 at 5:00 p.m. EDT; transcript provider secondary | Management’s explanation of U.S. DTC traffic and early-Q4 recovery; treated as company commentary, not realized Q4 result |
| Levi Strauss earlier Q2 long article | July 16, 2026 | Prior thesis boundary; Q2 growth, pending ASR settlement and $1.46–$1.52 adjusted-EPS guide |
| LEVI regular-session price history | Oct. 7, 2026 close | $19.51 close, -4.97%, $19.35–$20.39 range, 18.03M shares |
| LEVI after-hours quote and 52-week range | Oct. 7, 2026 after hours | $19.15 late mark; $17.72 low and $25.70 high are historical references, not bounds |
| LEVI after-hours close and short-interest settlement | Oct. 7, 8:04 p.m. EDT quote; Sep. 15 SI | $19.1497 after-hours mark; 8.046M shares short, 8.18% of ChartMill float and 3.65 days to cover |
| Conflicting LEVI short-interest denominator | Sep. 15 settlement report | Same 8.046M shares, but MarketBeat reports 2.11% of public float and 3.8 days; float mismatch unresolved |
| LEVI pre-release consensus snapshot | Before Oct. 7 release | $0.36 EPS and $1.62B revenue estimates; secondary consensus only |
| Applied Digital Q1 FY2027 issuer release | Oct. 7, 2026 | GAAP loss, adjusted EBITDA, base rent vs fit-out revenue, lease portfolio, cash and debt for comparator |
| APLD price history and after-hours quote | Oct. 7, 2026 regular close / 7:59 p.m. EDT | $23.81 close, 48.76M shares, $24.94 after-hours mark |
| APLD short-interest settlement | Sep. 15, 2026 | 57.864M shares short, 21.88% reported float; stale and not live borrow data |
| PepsiCo Q3 release timing notice | Aug. 25, 2026 | Q3 materials scheduled at 6:00 a.m. EDT Oct. 8 and analyst Q&A at 8:15 a.m. EDT |
| PepsiCo Q2 FY2026 issuer release | July 9, 2026 | Last completed issuer result before the Q3 release; used only as pending-event context |
| U.S. market close report | Oct. 7, 2026 | S&P 500 -0.2% and Russell 2000 -1.3% broad-market control |
Research Quality Scorecard
| Criterion | Score | Basis |
|---|---|---|
| Market disagreement | 3/5 | DTC and tariff-adjusted margin risks coexist with raised guidance and positive company-reported Q4 trends |
| Evidence base | 4/5 | Fresh issuer results and call, verified after-hours quotes and an older prior thesis; no next-session acceptance |
| Positioning and flows | 3/5 | Sep. 15 short count is known but float percentages conflict; current borrow and account-level flow unknown |
| Catalyst path | 4/5 | First post-result regular session and Nov. 29 fiscal year-end are testable; short-term price path still noisy |
| Payoff architecture | 2/5 | Flat base, only 7.5% top historical downside, 6.5% adverse rebound and negative expected price-only value |
| Invalidation discipline | 4/5 | Oct. 8 close, Q4 DTC, margin, tariff reinvestment and actual ASR execution are explicit tests |
| Differentiated insight | 4/5 | Separates reported EPS/margin from tariff windfall and compares the July long thesis with Q3 evidence |
| Client value | 4/5 | Explains why the mixed print and after-hours fade do not clear a bounded short |
| Total | 28/40 | Reject / no-trade screen; failed 10/5 economics override score |
Bottom Line
LEVI’s Q3 is weaker than its adjusted-EPS headline but stronger than a short thesis needs it to be: organic sales grew, margin improved after stripping out most of a tariff-refund boost, management raised full-year profit guidance and said early-Q4 DTC had returned to positive growth. From $19.15 after hours, the reference map lacks a 10% base decline and already contains a 6.5% rebound stress. The July long thesis is materially updated, but no short with bounded downside emerges. Reject; no trade.
AI Illustration Prompt: Create a restrained institutional illustration for The Mispricing Desk: a Levi’s denim jacket hangs between two retail channels, a store and an online parcel stream. Above the jacket, a margin bridge separates “Q3 ADJ EBIT 15.5%” into “12.2% illustrative ex-net-refund” plus “3.3 pts net tariff benefit,” with a footnote-like tag “company estimate; simple subtraction.” Below, show “DTC comp: flat” opposite “Wholesale organic: +6%,” while a small callout reads “U.S. DTC Q4: early positive trend, management commentary.” Add a quiet price strip “$19.15 AH / $17.72 LOW / $20.39 OCT 7 HIGH — REFERENCE ONLY.” Use indigo, warm cream, muted amber and graphite; avoid a red collapse arrow or a trade instruction. Include a subtle readable “The Mispricing Desk” watermark.